IN a recent communication, Biekerstaff et al. 1 were unable to demonstrate differences between the synaptic regions of myasthenic and non-myasthenic patients when muscle biopsies were examined by ...

New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD). In preclinical DMD mouse models, investigators demonstrated ...

The landscape of peptide-based research continues to broaden as investigators pursue compounds capable of interacting with molecular networks involved in cellular communication, structural maintenance ...

Findings published in The American Journal of Pathology identify GLUD1 enzyme as a potential therapeutic target for muscle restoration through metabolic reprogramming, addressing clinically unmet need ...